secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2024-06-13T23:59:59+00:00
Accession:  0001104659-24-071253
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immunome stockholders elect Siegall and Schafer as Class I directors; E&Y ratified
--------------------------------------------------------------------------------

- Clay B. Siegall elected with 43,295,914 votes for, 80,139 withheld; broker non-votes 6,682,195.
- Carol A. Schafer elected with 33,452,580 votes for, 9,923,473 withheld; broker non-votes 6,682,195.
- Ratification of Ernst & Young as auditor for FY2024: 50,008,641 for, 29,664 against, 19,943 abstain; no broker non-votes.
- Annual Meeting held June 12, 2024; 59,943,368 shares outstanding and entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000110465924071253/0001104659-24-071253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000110465924071253/tm2417104d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-071253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer